Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term chemoradiation. Found 24 abstracts

no pagination
Fareed MM, DeMora L, Esnaola NF, Denlinger CS, Karachristos A, Ross EE, Hoffman J, Meyer JE. Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas. Journal of gastrointestinal oncology. 2018 Aug;9(4):762-8.   PMCID: PMC6087856
Shaikh T, Meyer JE, Horwitz EM. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Surg Oncol Clin N Am. 2017 Jul;26(3):405-29.   PMCID: REVIEW
Marur S, Burtness B. Oropharyngeal squamous cell carcinoma treatment: current standards and future directions. Current Opinion in Oncology. 2014 May;26(3):252-8.   PMCID: No NIH funding
Wanebo HJ, Lee J, Burtness BA, Ridge JA, Ghebremichael M, Spencer SA, Psyrri D, Pectasides E, Rimm D, Rosen FR, Hancock MR, Tolba KA, Forastiere AA. Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303). Ann Oncol. 2014 Oct;25(10):2036-41.   PMCID: Pmc4176450
Berger AC, Winter K, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Benson AB, MacDonald J, Willett CG. Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 <= 90 U/mL and Comparison to the CONKO-001 Trial. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(3):E291-E297.
Berger AC, Winter K, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Benson AB, MacDonald J, Willett CG. Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 <= 90 U/mL and Comparison to the CONKO-001 Trial. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(3):E291-E297.
Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Mar;82(4):1367-75.   PMCID: PMC3208721
Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, Meron Aj VP. Esophageal and Esophagogastric Junction Cancers. Journal of the National Comprehensive Cancer Network. 2011 Aug;9(8):830-+.   PMCID: not NIH funded
Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G, Nccn Gastric Canc Panel Members. Gastric Cancer Clinical Practice Guidelines in Oncology (TM). Journal of the National Comprehensive Cancer Network. 2010 Apr;8(4):378-409.   PMCID: not NIH funded
Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP. Defining Venous Involvement in Borderline Resectable Pancreatic Cancer. Annals of Surgical Oncology. 2010 Nov;17(11):2832-8.   PMCID: no NIH funding
Hoffman JP. Status of Neoadjuvant Therapy for Resectable Pancreatic Cancer. Surgical Oncology Clinics of North America. 2010 Apr;19(2):411-+.   PMCID: not NIH funded
Rosenthal DI, Catalano PJ, Haller DG, Landry JC, Sigurdson ER, Spitz FR, Benson AB. Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297. International Journal of Radiation Oncology Biology Physics. 2008 Sep;72(1):108-13.
Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF. Patterns of care survey (PCS) in lung cancer: how well does current US practice with chemotherapy in the non-metastatic setting follow the literature?. Lung Cancer. 2005 Apr;48(1):93-102.
Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01. Journal of Clinical Oncology. 2005 Apr;23(10):2145-54.
Glisson B, Scott C, Komaki R, Movsas B, Wagner H. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: Results of radiation therapy oncology group trial 93-12. Journal of Clinical Oncology. 2000 Aug;18(16):2990-5.
Coia LR, Gunderson LL, Haller D, Hoffman J, Mohiuddin M, Tepper JE, Berkey B, Owen JB, Hanks GE. Outcomes of patients receiving radiation for carcinoma of the rectum - Results of the 1988-1989 patterns of care study. Cancer. 1999 Nov 15;86(10):1952-8.
Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An eastern cooperative oncology group study. Journal of Clinical Oncology. 1998 Jan;16(1):317-23.
Hoffman JP, Pendurthi TK, Ross E, Yeung RS. Preoperative radiation therapy and chemotherapy for adenocarcinoma of the pancreas. Hepato-Gastroenterology. 1998 May;45(21):634-7.
Keller SM, Ryan LM, Coia LR, Dang P, Vaught DJ, Diggs C, Weiner LM, Benson AB. High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction - Results of a phase II study of the Eastern Cooperative Oncology Group. Cancer. 1998 Nov;83(9):1908-16.
Montgomery RC, Hoffman JP, Riley LB, Rogatko A, Ridge JA, Eisenberg BL. Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Annals of Surgical Oncology. 1997 Oct;4(7):551-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term chemoradiation

chemoradiation chemotherapy adenocarcinoma cancer radiotherapy carcinoma pancreaticoduodenectomy resection phase-ii trial randomized controlled-trial chemoradiotherapy ca-19-9 squamous-cell carcinoma surgery survival head pathological complete response curative resection intensity-modulated radiotherapy positron-emission-tomography high-grade dysplasia combined modality therapy NCCN Clinical Practice Guidelines carboplatin cisplatin gemcitabine long-term survival TRIAL serum phase-iii trial radiation-therapy postoperative trial resectable pancreatic-cancer endoscopic mucosal resection multicenter phase-ii concurrent chemotherapy prognosis IMPACT Patterns of Care Study esophageal cancer randomized-trial Eastern Cooperative Oncology Group oncology phase I vascular resection ii preoperative chemoradiation COLORECTAL-CARCINOMA s-1 plus minimally invasive esophagectomy trimodality gastroesophageal Cancer NCCN Guidelines postoperative radiotherapy Oncology ductal adenocarcinoma TUMOR-REGRESSION concurrent Rectal SURVIVAL preoperative radiotherapy smoking CANCER COOPERATIVE-ONCOLOGY-GROUP patterns of care survey radiation therapy intensification mitomycin- Chemotherapy junction adenocarcinoma Neoadjuvant therapy multidisciplinary care TOTAL MESORECTAL EXCISION HUMAN-PAPILLOMAVIRUS lymphoma esophageal neoplasm malignancies stage-ii quality-of-life invitro hyperfractionated radiation-therapy biologic therapy esophageal Resectable pancreatic adenocarcinoma lung cancer lymph-node dissection metaanalysis head and neck squamous cell cancer oxaliplatin therapy modality therapy cholangiocarcinoma (CCA) organ resection (JNCCN 8:378-409) induction chemotherapy margin status full-dose gemcitabine Radiotherapy adjuvant therapy novel targets in esophagogastric junction expert consensus statement tumor-marker human papilloma virus recurrence UNITED-STATES concurrent radiation computed-tomography resectable adenocarcinoma arbeitsgemeinschaft internistische onkologie 3-dimensional conformal radiotherapy neoadjuvant adjuvant treatment preservation thoracic radiotherapy RANDOMIZED PHASE-II NECK-CANCER rectal cancer esophagectomy medical oncology combined-modality therapy pancreas RADIOTHERAPY head–neck fluorouracil prospective randomized trial Neoadjuvant oropharynx cancer dose-escalation study neoadjuvant chemoradiotherapy CHEMORADIOTHERAPY ORAL-CAVITY CA 19-9 upper gastrointestinal preoperative chemotherapy clinical-trials gastric carcinoma 2010 HEAD CONCURRENT CHEMORADIOTHERAPY radiation term-follow-up antigen imrt c rectal carcinoma de-escalation
Last updated on Wednesday, February 05, 2020